Palantir Stock Has Been Getting Slammed. Time to Buy?

Palantir Technologies (PLTR) reported exceptional Q2 results, with revenue up 48% year-over-year to over $1 billion, driven by 93% growth in U.S. commercial revenue, alongside robust GAAP net income of $327 million and a record $2.3 billion in total contract value. Management also raised full-year revenue guidance to 45% growth. Despite this strong operational momentum, the stock, which has cooled off recently but remains significantly up year-to-date, faces an 'egregious' valuation, trading at 127 times sales and 580 times P/E, indicating the market has already priced in years of extraordinary growth and leaving limited room for error for new investment.

Analysis

Palantir Technologies (PLTR) delivered exceptional second-quarter operational results, characterized by a 48% year-over-year revenue increase to over $1 billion, significantly driven by a 93% surge in its U.S. commercial revenue segment. This top-line momentum is supported by strong forward-looking indicators, including a record total contract value of $2.3 billion, up 140% YoY, and upwardly revised guidance for full-year revenue growth of approximately 45%. The company also demonstrated a significant milestone in profitability, reporting a robust GAAP net income of $327 million. However, these stellar fundamentals are juxtaposed with what the report describes as an 'egregiously' high valuation. The stock trades at 127 times sales and 580 times earnings, multiples that dwarf the S&P 500's P/E of 25. This suggests that the market has already priced in years of flawless execution and extraordinary growth, leaving virtually no margin for error and making the stock highly vulnerable to any future disappointments.

Key Decisions for Investors

• Given the stock's extreme valuation with a price-to-sales ratio of 127, prospective investors should exercise caution as the current price appears to fully reflect a multi-year, best-case growth scenario, creating a high-risk entry point.
• Current holders who have benefited from the stock's significant appreciation should consider trimming positions to realize gains, as the risk/reward profile is now skewed by a valuation that leaves no room for operational missteps.
• Investors should closely monitor future U.S. commercial revenue growth and overall contract value, as any deceleration from the current high rates could serve as a negative catalyst and trigger a significant price correction.